Literature DB >> 17435943

Aripiprazole worsening positive symptoms and memantine reducing negative symptoms in a patient with paranoid schizophrenia.

Milena Pereira Pondé, Camila Marinho Novaes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17435943     DOI: 10.1590/s1516-44462007000100028

Source DB:  PubMed          Journal:  Braz J Psychiatry        ISSN: 1516-4446            Impact factor:   2.697


× No keyword cloud information.
  5 in total

Review 1.  Pharmacological and clinical profile of recently approved second-generation antipsychotics: implications for treatment of schizophrenia in older patients.

Authors:  Jeffrey Rado; Philip G Janicak
Journal:  Drugs Aging       Date:  2012-10       Impact factor: 3.923

Review 2.  The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence.

Authors:  Gabriele Sani; Giulia Serra; Giorgio D Kotzalidis; Silvia Romano; Stefano M Tamorri; Giovanni Manfredi; Matteo Caloro; C Ludovica Telesforo; Saverio S Caltagirone; Isabella Panaccione; Alessio Simonetti; Francesca Demontis; Gino Serra; Paolo Girardi
Journal:  CNS Drugs       Date:  2012-08-01       Impact factor: 5.749

Review 3.  Aripiprazole for late-life schizophrenia.

Authors:  Jeffrey Rado; Philip G Janicak
Journal:  Clin Interv Aging       Date:  2010-09-07       Impact factor: 4.458

Review 4.  A systematic review of reported cases involving psychotic symptoms worsened by aripiprazole in schizophrenia or schizoaffective disorder.

Authors:  Hiroyoshi Takeuchi; Gary Remington
Journal:  Psychopharmacology (Berl)       Date:  2013-06-05       Impact factor: 4.530

5.  Increased Anxiety, Akathisia, and Suicidal Thoughts in Patients with Mood Disorder on Aripiprazole and Lamotrigine.

Authors:  Milena Pereira Pondé; Antonio Carlos Cruz Freire
Journal:  Case Rep Psychiatry       Date:  2015-10-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.